Patents by Inventor Bernat GALMÉS SUREDA

Bernat GALMÉS SUREDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220381797
    Abstract: Devices and methods for determining activity of one or more coagulation factors in a blood sample are provided. The device may comprise an inlet port for deposition of a sample, a reaction compartment, a detection compartment, a control compartment, or any combination thereof. One or more compartments may be fluidically connected. One or more compartments may comprise plasma deficient of a coagulation factor, an ionic citrate source, an ionic calcium source, one or more coagulation contact phase activator reagents, a phospholipid, or a mixture, or any combination thereof.
    Type: Application
    Filed: June 16, 2022
    Publication date: December 1, 2022
    Inventors: Bernat GALMÈS SUREDA, Mariana Isabel Canaro Hirnyk, Vicente R. Cortina Giner
  • Patent number: 10969397
    Abstract: Test strips for determining the activity of a coagulation factor in a blood sample are provided. The strip comprises a support, a sample inlet port for deposition of a blood sample, and a reaction area comprising a blood coagulation reagent. The sample inlet port is connected to the reaction area, and the coagulation reagent comprises blood plasma deficient in the coagulation factor for which activity is to be measured, an ionic citrate source an ionic calcium source, and either one or more coagulation contact phase activator reagents and phospholipids or a mixture of tissue factor and phospholipids. The disclosure further relates to in vitro methods for measuring an activity of a coagulation factor.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: April 6, 2021
    Assignee: CGT ENTERPRISES, LLC
    Inventors: Bernat Galmés Sureda, Mariana Isabel Canaro Hirnyk, Vicente R. Cortina Giner
  • Publication number: 20190383838
    Abstract: Test strips for determining the activity of a coagulation factor in a blood sample are provided. The strip comprises a support, a sample inlet port for deposition of a blood sample, and a reaction area comprising a blood coagulation reagent. The sample inlet port is connected to the reaction area, and the coagulation reagent comprises blood plasma deficient in the coagulation factor for which activity is to be measured, an ionic citrate source an ionic calcium source, and either one or more coagulation contact phase activator reagents and phospholipids or a mixture of tissue factor and phospholipids. The disclosure further relates to in vitro methods for measuring an activity of a coagulation factor.
    Type: Application
    Filed: August 26, 2019
    Publication date: December 19, 2019
    Inventors: Bernat GALMÉS SUREDA, Mariana Isabel CANARO HIRNYK, Vicente R. CORTINA GINER
  • Patent number: 10436805
    Abstract: Test strips for determining the activity of a coagulation factor in a blood sample are provided. The strip comprises a support, a sample inlet port for deposition of a blood sample, and a reaction area comprising a blood coagulation reagent. The sample inlet port is connected to the reaction area, and the coagulation reagent comprises blood plasma deficient in the coagulation factor for which activity is to be measured, an ionic citrate source an ionic calcium source, and either one or more coagulation contact phase activator reagents and phospholipids or a mixture of tissue factor and phospholipids. The disclosure further relates to in vitro methods for measuring an activity of a coagulation factor.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: October 8, 2019
    Assignee: CGT ENTERPRISES, LLC
    Inventors: Bernat Galmés Sureda, Mariana Isabel Canaro Hirnyk, Vicente R. Cortina Giner
  • Publication number: 20170212134
    Abstract: Test strips for determining the activity of a coagulation factor in a blood sample are provided. The strip comprises a support, a sample inlet port for deposition of a blood sample, and a reaction area comprising a blood coagulation reagent. The sample inlet port is connected to the reaction area, and the coagulation reagent comprises blood plasma deficient in the coagulation factor for which activity is to be measured, an ionic citrate source an ionic calcium source, and either one or more coagulation contact phase activator reagents and phospholipids or a mixture of tissue factor and phospholipids. The disclosure further relates to in vitro methods for measuring an activity of a coagulation factor.
    Type: Application
    Filed: April 10, 2017
    Publication date: July 27, 2017
    Inventors: Bernat GALMÉS SUREDA, Mariana Isabel CANARO HIRNYK, Vicente R. CORTINA GINER
  • Patent number: 9651567
    Abstract: Test strips for determining the activity of a coagulation factor in a blood sample are provided. The strip comprises a support, a sample inlet port for deposition of a blood sample, and a reaction area comprising a blood coagulation reagent. The sample inlet port is connected to the reaction area, and the coagulation reagent comprises blood plasma deficient in the coagulation factor for which activity is to be measured, an ionic citrate source an ionic calcium source, and either one or more coagulation contact phase activator reagents and phospholipids or a mixture of tissue factor and phospholipids. The disclosure further relates to in vitro methods for measuring an activity of a coagulation factor.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: May 16, 2017
    Assignee: CGT Enterprises, LLC
    Inventors: Bernat Galmés Sureda, Mariana Isabel Canaro Hirnyk, Vicente R. Cortina Giner
  • Publication number: 20160091513
    Abstract: Test strips for determining the activity of a coagulation factor in a blood sample are provided. The strip comprises a support, a sample inlet port for deposition of a blood sample, and a reaction area comprising a blood coagulation reagent. The sample inlet port is connected to the reaction area, and the coagulation reagent comprises blood plasma deficient in the coagulation factor for which activity is to be measured, an ionic citrate source an ionic calcium source, and either one or more coagulation contact phase activator reagents and phospholipids or a mixture of tissue factor and phospholipids. The disclosure further relates to in vitro methods for measuring an activity of a coagulation factor.
    Type: Application
    Filed: February 21, 2014
    Publication date: March 31, 2016
    Applicant: STRUSZYM, S.L.
    Inventors: Bernat GALMÉS SUREDA, Mariana Isabel CANARO HIRNYK, Vicente R. CORTINA GINER